• Free Shipping Icon

    Receive Free Shipping To The More Store!*

    *Marketplace items do not qualify for the free shipping promotion.

List Price: $266.66

Rent Textbook

Select for Price
There was a problem. Please try again later.

New Textbook

We're Sorry
Sold Out

Used Textbook

We're Sorry
Sold Out

eTextbook

We're Sorry
Not Available

How Marketplace Works:

  • This item is offered by an independent seller and not shipped from our warehouse
  • Item details like edition and cover design may differ from our description; see seller's comments before ordering.
  • Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
  • Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
  • Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.

Summary

This book is a comprehensive textbook of the neurological, behavioural, motor, sensory, cognitive, psychiatric, developmental and basic research performed on HIV-1 infection of the nervous system. The contributors represent some of the foremost clinical and basic science investigators in thefield of NeuroAIDS worldwide. Particular emphasis is placed on current thinking with regard to disease pathogenesis, patient care, and the prospects for the future. Human immunodeficiency virus, type 1 (HIV-1) infection can often lead to a number of neurological events including peripheral neuropathy, myopathy, vacuolar myelopathy; and cognitive, motor and behavior abnormalities. The mechanisms by which the virus invades the nervous system and inducesneurological deficits are the focal points of this book. Such topics are covered from the laboratory bench to the patient bedside. Considerable emphasis is placed in how research is performed at the molecular, cellular, animal model and patient levels. The work includes considerable emphasis onthe epidemiology, psychological and psychiatric aspects of the disease complex. A complete section on the clinical aspects of disease is included, as a first time effort using patients to describe disease manifestations rather than physicians or researchers. The emerging new fields of genomics andproteomics have begun to better define the host factors that permit active viral production in the brain as well as lead to a secretion of a plethora of inflammatory and cytotoxic factors that lead to neuronal injury and subsequent death. Such processes not only define AIDS Neurology but also arethe underbelly of most neurodegenerative disorders including, but not limited to, Alzheimer s and Parkinson s disease, amyotrophic lateral sclerosis and Huntington s disease. Significant advances in antiretroviral viral therapy have markedly diminished the incidence of HIV-1 associated dementia (HAD) while peripheral neuropathy remains a common disorder. Neuropsychological methods to monitor cognitive impairments are more precise, and as patients live longer withdisease more subtle neurological manifestations of disease have emerged. Incredible advances in studies of viral neuropathogenesis, diagnostics, and therapeutics for HAD and much more are covered in the book. A number of germane questions have been addressed in a comprehensive manner includingissues relating to HIV-1 neurovirulence and neurotropism, cellular factors influencing viral replication, therapeutic challenges, and the changing epidemiological patterns of disease including peripheral neuropathy. The contributors to this book represent some of the foremost clinical and basic science investigators in the field of NeuroAIDS worldwide.

Table of Contents

Contributors xix
Abbreviations xxiii
Overview: a panel discussion: critical topics in the neurology of AIDS 1(11)
Howard E. Gendelman
J. Hampton Atkinson
Ian Paul Everall
R. Gilberto Gonzalez
Igor Grant
Robert Heaton
Dennis L. Kolson
Stuart A. Lipton
Justin McArthur
Avindra Nath
Christopher Power
Susan Swindells
Brian Wigdahl
Priorities of the National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke for neuroAIDS research in resource-limited countries 12(5)
Jeymohan Joseph
Michael Nunn
HIV-1 biology, immunology, and neurovirulence
The molecular biology of HIV-1
17(12)
Anuja Ghorpade
Beda Brichacek
Michael Bukrinsky
Immunology of HIV-1
29(20)
Krishnakumar Devadas
Renu B. Lal
Subhash Dhawan
HIV-1 structural and regulatory proteins and neurotoxicity
49(8)
Mariantoinetta Di Stefano
Farideh Sabri
Francesca Chiodi
The genetic bases of HIV-1 neuropathogenesis
57(14)
Guido van Marle
Christopher Power
Innate and acquired immunity in HIV-1 dementia
Mononuclear phagocyte heterogeneity and the blood-brain barrier: a model for HIV-1 neuropathogenesis
71(14)
William F. Hickey
Kenneth C. Williams
Sarah Corey
Woong-Ki Kim
Common immune pathways of neural injury in neurodegenerative disorders
85(10)
Sunhee C. Lee
Dennis W. Dickson
HIV-1 vaccines
95(12)
R. Lee Mosley
Eric J. Benner
The blood--brain barrier and HIV-1
The blood--brain barrier: its structure and function
107(8)
William A. Banks
The blood--brain barrier as an immunocompetent organ
115(10)
Donald W. Miller
Viral receptors and the mechanisms of HIV-1 entry into cells and the central nervous system
125(22)
Julio Martin-Garcia
Francisco Gonzalez-Scarano
Mechanisms of viral entry through the blood-brain barrier
147(8)
Eliseo A. Eugenin
Joan W. Berman
The blood--brain barrier: monocyte and viral entry into the brain
155(8)
Hans S.L.M. Nottet
The choroid plexus and viral entry into the brain
163(14)
Evan Burkala
John T. West
Jun He
Carol K. Petito
Charles Wood
Mechanisms of neurotoxicity by HIV-1 and cellular immune products
Mechanisms of macrophage-mediated neurotoxicity
177(4)
Marc Tardieu
Chemokines, HIV-1, and the central nervous system
181(12)
Richard J. Miller
Mechanisms of neuronal demise in HIV dementia: role of HIV-1 Tat
193(8)
Ashok Chauhan
Avi Nath
Protection against HIV-1 gp 120 and HIV-1 Tat neurotoxicity
201(10)
Apsara Kandanearatchi
Avindra Nath
Stuart A. Lipton
Eliezer Masliah
Ian Paul Everall
Astrocyte immunobiology
211(14)
Etty (Tika) Benveniste
Dale J. Benos
Transcriptional analysis of inflammatory and glial responses in the central nervous system: development of RNA fingerprints for neuroAIDS and other central nervous system disorders
225(14)
Eleanor S. Roberts
Howard S. Fox
Neurogenesis and its links to brain development, developmental therapeutics, and the pathogenesis of neurodegenerative disorders including HIV-1-associated dementia
239(18)
Jialin Zheng
Hui Peng
Jeremy Rose
Shelley Herek
Animal model systems
The simian immunodeficiency virus/macaque model: detailing viral weapons and host defenses in HIV central nervous system disease
257(12)
M. Christine Zink
Tahar Babas
Joseph L. Mankowski
Lucy M. Carruth
Sheila A. Barber
Janice E. Clements
The feline immunodeficiency virus model of HIV-1-associated neurological disease
269(10)
Rick B. Meeker
D. Christopher Bragg
Neurological disease produced by maedi--visna and caprine arthritis--encephalitis viruses, lentiviruses of sheep and goats
279(10)
Valgerdur Andresdottir
Sigurbjorg Torsteinsdottir
Gudmundur Georgsson
Murine model systems for studies of HIV-1-associated dementia
289(8)
Yuri Persidsky
Studies of adaptive immunity in a murine model of HIV-1 encephalitis
297(12)
Larisa Y. Poluektova
Santhi Gorantla
Howard E. Gendelman
Laboratory model systems of drug abuse and their relevance to HIV infection and dementia
309(14)
Thomas J. Rogers
Filip Bednar
David E. Kaminsky
Penelope C. Davey
Joseph J. Meissler Jr
Toby K. Eisenstein
Living with HIV and AIDS (clinical perspectives from patients living with the neurological consequences of HIV infection)
HIV dementia: living with the suffering, the diagnosis, and the uncertainties
323(2)
Karen
Neurological manifestations of HIV disease
325(2)
Garrett Burton
Coping with depression
327(4)
Sebron Kendrick
Living with HIV in an African community: a mental health point of view
331(4)
Roy Brazington
Tracy Ramsden
HIV and sexual dysfunction: a patient's view
335(4)
Ian Kramer
Clinical and pathological aspects of disease
An overview of the clinical and biological features of the AIDS dementia complex
339(20)
Bradford A. Navia
Richard W. Price
HIV neurocognitive disorders
359(16)
Igor Grant
Ned Sacktor
Justin McArthur
The neuropathology of HIV--associated brain disease
375(18)
Herbert Budka
Brain pathology in HIV-1-infected drug abusers
393(12)
Jeanne E. Bell
Francoise Gray
Current concepts in HIV neuropathogenesis: neuronal injury, white matter disease, and neurotrophic factors
405(10)
T.D. Langford
Ian Paul Everall
Eliezer Masliah
Spinal cord disease: clinical presentations and pathology
415(8)
Luca Mazzella
Alessandro Di Rocco
Michele Tagliati
The spectrum of peripheral neuropathies in AIDS
423(22)
Sanjay Keswani
Carlos Luciano
Carlos Pardo
Kate Cherry
Ahmet Hoke
Justin C. McArthur
The neuropathology of HIV-related neuropathies
445(4)
Bruce J. Brew
Myopathies associated with HIV-1: clinical and pathological manifestations
449(12)
Kenneth A. Fox
Susan Morgello
David M. Simpson
Human polyomavirus, JC virus, and progressive multifocal leukoencephalopathy
461(14)
Mahmut Safak
Eugene Major
Kamel Khalili
Central nervous system neoplasms in AIDS
475(10)
Alexis Demopolous
Lauren Abrey
Opportunistic infections of the nervous system in AIDS
485(46)
Joseph R. Berger
Bruce A. Cohen
Hepatitis C
531(10)
Vincent Soriano
Marina Nunez
Luz Martin-Carbonero
Pablo Barreiro
Javier Garcia-Samaniego
Juan Gonzalez-Lahoz
Alcohol and HIV-1 neuropathogenesis
541(12)
Edward Acheampong
Muhammad Mukhtar
Roger J. Pomerantz
Psychiatric disorders
553(14)
J. Hampton Atkinson
Cheryl Person
Corinna Young
David Deitch
Glenn Treisman
Diagnostic methods for monitoring cognitive function in neuroAIDS
Structural brain imaging
567(8)
Terry Jernigan
Sarah Archibald
Magnetic resonance spectroscopy of animal models of neuroAIDS
575(10)
Jane Greco
R. Gilberto Gonzalez
Magnetic resonance spectroscopy and functional magnetic resonance imaging in the evaluation of HIV-associated brain injury
585(16)
Linda Chang
Thomas Ernst
Evoked potentials
601(6)
Vicente J. Iragui
John Olichney
Neuropsychology of HIV
607(10)
Steven Paul Woods
Igor Grant
The effects of antiretroviral therapy on viral and nonviral markers in cerebrospinal fluid
617(12)
Scott Letendre
Compartmentalization of HIV infection in the central nervous system
629(10)
Chi Hung
Ronald J. Ellis
HIV-1 encephalopathy: unique aspects in children and adolescents
Clinical features
639(20)
Mark Mintz
Neuropathological aspects of HIV-1 infection in children
659(8)
Leroy R. Sharer
Evaluation of neurodevelopmental deficits in children with HIV-1 infection
667(16)
Pamela L. Wolters
Pim Brouwers
Psychosocial aspects of neurological impairment in children with AIDS
683(10)
Lori Wiener
Staci Martin
Antiretroviral therapy in children
693(20)
Lauren V. Wood
Antiretroviral and adjunctive drug strategies for neuroAIDS and treatment of opportunistic infections
Current concepts in the treatment of HIV infection with focus on brain disease
713(8)
Susan Swindells
Treatment of opportunistic infections associated with HIV infection
721(8)
David B. Clifford
Pharmacology of antiretroviral drugs in the central nervous system: pharmacokinetics, antiretroviral resistance, and pharmacodynamics
729(6)
J. Allen McCutchan
Scott L. Letendre
Development of adjunctive therapies for the neurological manifestations of AIDS: dementia and painful neuropathy
735(8)
Stuart A. Lipton
Harris A. Gelbard
Social and behavioral consequences of HIV infection
Everyday impact of HIV-associated neurocognitive disorders
743(12)
Thomas D. Marcotte
Robert K. Heaton
Steven Albert
Coping, methamphetamine, and HIV-1
755(10)
Thomas L. Patterson
Shirley J. Semple
Club drugs and HIV transmission
765(10)
Andrew Mattison
Mariana Cherner
Facing legal and ethical challenges in the treatment of AIDS
775(12)
Warren B. Treisman
Glenn Treisman
AIDS-related death anxiety: a research review and clinical recommendations
787(14)
Robert A. Neimeyer
Alan E. Stewart
John R. Anderson
Clinical-neuropathological correlation in HIV in the era of highly active antiretroviral therapy
801(12)
Ronald J. Ellis
Annette Merdes
Eliezer Masliah
T.D. Langford
Pain management in HIV infection
813(10)
Mathew Lefkowitz
Igor Grant
Index 823

An electronic version of this book is available through VitalSource.

This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.

By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.

Digital License

You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.

More details can be found here.

A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.

Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.

Please view the compatibility matrix prior to purchase.